The role of erenumab in the treatment of migraine

Calcitonin gene related peptide (CGRP) monoclonal antibodies (mAbs) have been the first class of specifically developed preventive treatments for migraine. Clinical trials data suggest superiority of the CGRP mAbs to placebo in terms of prevention of migraine symptoms, migraine-specific quality of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreou, Anna P., Fuccaro, Matteo, Lambru, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257830/
https://www.ncbi.nlm.nih.gov/pubmed/32523630
http://dx.doi.org/10.1177/1756286420927119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257830/
https://www.ncbi.nlm.nih.gov/pubmed/32523630
http://dx.doi.org/10.1177/1756286420927119

Ejemplares similares